Mercia Research
HomePeptidesDiagramsQuizAbout

Compounds

The compound library.

Ten research compounds, each with an honest, evidence-graded summary of the published literature.

Synthetic peptide (gastric-derived)

BPC-157

A stable gastric pentadecapeptide studied for tissue-repair pathways.

Mostly preclinical
Peptide fragment (Thymosin β4)

TB-500 (Thymosin β4)

A synthetic fragment of Thymosin β4 studied for cell migration and tissue repair.

Mostly preclinical
Growth-hormone secretagogue (ghrelin/GHS-R agonist)

Ipamorelin

The first highly selective GH secretagogue.

Foundational only
GHRH analogue

CJC-1295 (no DAC / Mod GRF 1-29)

A DPP-4-resistant GHRH analogue that stimulates GH/IGF-1.

Foundational only
GHRH(1-44) analogue

Tesamorelin

An FDA-approved GHRH analogue for HIV-associated lipodystrophy.

Human RCT evidence
Anxiolytic heptapeptide (tuftsin analogue)

Selank

A synthetic tuftsin-derived peptide studied for anxiety and cognition.

Mostly preclinical
Nootropic/neuroprotective heptapeptide (ACTH 4-10 analogue)

Semax

A Russian-developed ACTH-fragment peptide studied for neuroprotection and cognition.

Mostly preclinical
Mitochondrial-derived peptide

MOTS-c

A mitochondrial-derived "mitokine" studied as an exercise-mimetic and metabolic regulator.

Mostly preclinical
Copper-binding tripeptide

GHK-Cu

A naturally occurring copper tripeptide studied for skin and wound repair.

Mixed
Coenzyme (not a peptide)

NAD+

A central metabolic coenzyme studied in ageing and metabolism.

Human trials (mixed outcomes)

For laboratory and scientific in vitro research use only. Not for human or animal consumption. Nothing on this site is medical advice or a therapeutic claim. Research summaries describe published findings; many compounds have limited or no human clinical data. © 2026 Mercia Research Limited.

Edit with